Computer simulation of glioma growth and morphology

NeuroImage

Volumn 37, Issue SUPPL. 1, 2007, Pages

  Frieboes, Hermann B ^a,b   Lowengrub, John S ^b,e   Wise, S ^b   Zheng, X ^b   Macklin, Paul ^b   Bearer, Elaine L ^c,d   Cristini, Vittorio ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c BROWN UNIVERSITY   (United States)

^d CALIFORNIA INSTITUTE OF TECHNOLOGY   (United States)

^e University of California at Irvine   (United States)

Author keywords

3D; Cancer model; Computer simulation; Glioblastoma; Glioma; Mathematical model; Tumor growth; Tumor morphology

Indexed keywords

OXYGEN;

APOPTOSIS; ARTICLE; CANCER GROWTH; CANCER INVASION; CELL ADHESION; CELL DENSITY; COMPUTER SIMULATION; GLIOMA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPOXIA; MATHEMATICAL MODEL; MITOSIS; PHENOTYPE; PRIORITY JOURNAL; VASCULARIZATION;

BRAIN NEOPLASMS; COMPUTER SIMULATION; DIFFUSION; GLIOMA; HUMANS; IMMUNOHISTOCHEMISTRY; MODELS, NEUROLOGICAL; NEOVASCULARIZATION, PATHOLOGIC; OXYGEN CONSUMPTION;

EID: 34547807824     PISSN: 10538119     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroimage.2007.03.008     Document Type: Article

References (113)

1. Adam J. General aspects of modeling tumor growth and the immune response. In: Adam J., and Bellomo N. (Eds). A Survey of Models on Tumor immune Systems Dynamics (1996), Birkhauser, Boston 15-87
2. Ambrosi D., and Guana F. Stress-modulated growth. Math. Mech. Solids. (2005) doi:10.1177/1081286505059739
3. Ambrosi D., and Preziosi L. On the closure of mass balance models for tumor growth. Math. Models Methods Appl. Sci. 12 (2002) 737-754
4. Anderson A.R.A. A hybrid mathematical model of solid tumor invasion: the importance of cell adhesion. Math. Med. Biol. 22 (2005) 163-186
5. Anderson A.R.A., and Chaplain M.A.J. Continuous and discrete models of tumour-induced angiogenesis. Bull. Math. Biol. 60 (1998) 857-899
6. Anderson D.M., McFadden G.B., and Wheeler A.A. Diffuse interface methods in fluid mechanics. Annu. Rev. Fluid Mech. 30 (1998) 139-165
7. Anderson A.R.A., Chaplain M.A.J., Newman E.L., Steele R.J.C., and Thompson A.M. Mathematical modeling of tumour invasion and metastasis. J. Theor. Med. 2 (2000) 129-154
8. Araujo R.P., and McElwain D.L.S. A history of the study of solid tumor growth: the contribution of mathematical modeling. Bull. Math. Biol. 66 (2003) 1039-1091
9. Augustin H.G. Tubes, branches, and pillars. The many ways of forming a new vasculature. Circ. Res. 89 (2001) 645-647
10. Bartels U., Hawkins C., Jing M., Ho M., Dirks P., Rutka J., Stephens D., and Bouffet E. Vascularity and angiogenesis as predictors of growth in optic pathway/hypothalamic gliomas. J. Neurosurg. 104 (2006) 314-320
11. Bello L., Lucini V., Costa F., Pluderi M., Giussani C., Acerbi F., Carrabba G., Pannacci M., Caronzolo D., Grosso S., Shinkaruk S., Colleoni F., Canron X., Tomei G., Deleris G., and Bikfalvi A. Combinatorial administration of molecules that simultaneously inhibit angiogenesis and invasion leads to increased therapeutic efficacy in mouse models of malignant glioma. Clin. Cancer Res. 10 (2004) 4527-4537
12. Bellomo N., and Preziosi L. Modeling and mathematical problems related to tumor evolution and its interaction with the immune system. Math. Comp. (2000) 413-452
13. Berger M., and Colella P. Local adaptive mesh refinement for shock hydrodynamics. J. Comp. Phys. 82 (1989) 64-84
14. Bernsen H.J.J.A., and van der Kogel A.J. Antiangiogenic therapy in brain tumor models. J. Neuro-oncol. 45 (1999) 247-255
15. Bernsen H.J.J.A., Rijken P.F.J.W., Oostendorp T., and van der Kogel A.J. Vascularity and perfusion of human gliomas xenografted in the athymic nude mouse. Br. J. Cancer 71 (1995) 721-726
16. Boegler O., and Mikkelsen T. Angiogenesis in glioma: molecular mechanisms and roadblocks to translation. The Cancer Journal 9 (2003) 205-213
17. Brandt A. Multi-level adaptive solutions to boundary-value problems. Math. Comput. 31 (1977) 333-390
18. Bullitt E., Zeng D., Gerig G., Aylward S., Joshi S., Smith J.K., Lin W., and Ewend M.G. Vessel tortuosity and brain tumor malignance: a blinded study. Acad. Radiol. 12 (2005) 1232-1240
19. Byrne H.M., and Chaplain M.A.J. Growth of necrotic tumors in the presence and absence of inhibitors. Math. Biosci. 135 (1996) 187-216
20. Byrne H.M., and Chaplain M.A.J. Modeling the role of cell-cell adhesion in the growth and development of carcinomas. Math. Comput. Model. 24 (1996) 1-17
21. Byrne H.M., and Chaplain M.A.J. Free boundary value problems associated with the growth and development of multicellular spheroids. Eur. J. Appl. Math. 8 (1997) 639-658
22. Byrne H.M., and Preziosi L. Modeling solid tumor growth using the theory of mixtures. Math. Meth. Biol. 20 (2003) 341-366
23. Cai W.-J., Scholz D., and Ziegelhoeffer T. Structural remodeling during growth of collateral vessels. In: Schaper W., and Schaper J. (Eds). Arteriogenesis (2004), Kluwer Academic Publishers, Boston
24. Carmeliet P., and Jain R.K. Angiogenesis in cancer and other diseases. Nature 407 (2000) 249-257
25. Chaplain M.A.J. Avascular growth, angiogenesis and vascular growth in solid tumours: the mathematical modelling of the stages of tumour development. Math. Comput. Model. 23 (1996) 47-87
26. Chaplain M.A.J., and Anderson A.R.A. Mathematical modeling of tissue invasion. In: Preziosi L. (Ed). Cancer Modeling and Simulation (2003), CRC Press 269-297
27. Chaplain M.A.J., and Lolas G. Mathematical modeling of cancer cell invasion of tissue: the role of the urokinase plasminogen activation system. Math. Models Methods Appl. Sci. 15 (2005) 1685-1734
28. Chaplain M.A.J., Graziano L., and Preziosi L. Mathematical modeling of the loss of tissue compression responsiveness and its role in solid tumor development. Math. Med. Biol. 23 (2006) 192-229
29. Condeelis J., Singer R.H., and Segall J.E. The great escape: when cancer cells hijack the genes for chemotaxis and motility. Annu. Rev. Cell Dev. Biol. 21 (2005) 695-718
30. Cristini V., Lowengrub J., and Nie Q. Nonlinear simulation of tumor growth. J. Math. Biol. 46 (2003) 191-224
31. Cristini V., Frieboes H.B., Gatenby R., Caserta S., Ferrari M., and Sinek J.P. Morphological instability and cancer invasion. Clin. Cancer Res. 11 (2005) 6772-6779
32. Cristini, V., Gatenby, R., Lowengrub, J., 2006. Multidisciplinary studies of tumor invasion and the role of the microenvironment. NIH 1R01CA127769-01.
33. Cursiefen C., Hofmann-Rummelt C., Kuechle M., and Schloetzer-Schrehardt U. Pericyte recruitment in human corneal angiogenesis: an ultrastructural study with clinicopathological correlation. Br. J. Ophtalmol. 87 (2003) 101-106
34. DeJaeger K., Kavanagh M.-C., and Hill R. Relationship of hypoxia to metastatic ability in rodent tumours. Br. J. Cancer 84 (2001) 1280-1285
35. Derycke L., Van Marck V., Depypere H., and Bracke M. Molecular targets of growth, differentiation, tissue integrity, and ectopic cell death in cancer cells. Cancer Biother. Radiopharm. 20 (2005) 579-588
36. Eble J.A., and Haier J. Integrins in cancer treatment. Curr. Cancer Drug Targets 6 (2006) 89-105
37. Ellis L.M., and Kirkpatrick P. Bevacizumab. Nat. Rev., Drug Discov. 4 (2005) S8-S9
38. Elvin P., and Garner A.P. Tumour invasion and metastasis: challenges facing drug discovery. Curr. Opin. Pharmacol. 5 (2005) 374-381
39. Fallenstein G.T., Hulce V.D., and Melvin J.W. Dynamic mechanical properties of human brain tissue. J. Biomech. 2 (1969) 217-226
40. Frieboes H.B., Zheng X., Sun C.-H., Tromberg B., Gatenby R., and Cristini V. An integrated computational/experimental model of tumor invasion. Cancer Res. 66 (2006) 1597-1604
41. Friedl P. Prespecification and plasticity: shifting mechanisms of cell migration. Curr. Opin. Cell Biol. 16 (2004) 14-23
42. Friedl P., and Wolf A. Tumor cell invasion and migration: diversity and escape mechanisms. Nat. Rev., Cancer 3 (2003) 362-374
43. Friedl P., Hegerfeldt Y., and Tilisch M. Collective cell migration in morphogenesis and cancer. Int. J. Dev. Biol. 48 (2004) 441-449 (Sp. Iss. SI)
44. Friedman A. A hierarchy of cancer models and their mathematical challenges. Discrete Contin. Dyn. Syst., Ser. B 4 (2004) 147-159
45. Garcke H., Nestler B., and Stinner B. A diffuse interface model for alloys with multiple components and phases, SIAM. J. Appl. Math. 64 (2004) 775-799
46. Gatenby R.A., Gawlinski E.T., Gmitro A.F., Kaylor B., and Gillies R.J. Acid-mediated tumor invasion: a multidisciplinary study. Cancer Res. 66 (2006) 5216-5223
47. Giese A., Loo M.A., Tran N., Haskett D., Coons S.W., and Berens M.E. Dichotomy of astrocytoma migration and proliferation. Int. J. Cancer 67 (1996) 275-283
48. Greenspan H.P. On the growth and stability of cell cultures and solid tumors. J. Theor. Biol. 56 (1976) 229-242
49. Hayot C., Debeir O., Van Ham P., Van Damme M., Kiss R., and Decaestecker C. Characterization of the activities of actin-affecting drugs on tumor cell migration. Toxicol. Appl. Pharmacol. 211 (2006) 30-40
50. 2 gradients in solid tumors in vivo: high-resolution measurements reveal a lack of correlation. Nat. Med. 3 (1997) 177-182
51. Holash J., Maisonpierre P.C., Compton D., Boland P., Alexander C.R., Zagzag D., Yancopoulos G.D., and Wiegand S.J. Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF. Science 284 (1999) 1994-1998
52. Holash J., Wiegand S.J., and Yancopoulos G.D. New model of tumor angiogenesis: dynamic balance between vessel regression and growth mediated by angiopoietins and VEGF. Oncogene 18 (1999) 5356-5362
53. Huang Q., Shen H.M., and Ong C.N. Emodin inhibits tumor cell migration through suppression of the phosphatidylinositol 3-kinase-Cdc42/Rac1 pathway. Cell. Mol. Life Sci. 62 (2005) 1167-1175
54. Jacqmin D. Calculation of two-phase Navier-Stokes flows using phase-field modeling. J. Comp. Phys. 155 (1999) 96-127
55. Jain R.K. Delivery of molecular medicine to solid tumors: lessons from in-vivo imaging of gene expression and function. J. Control. Release 74 (2001) 7-25
56. Jain R.K. Molecular regulation of vessel maturation. Nat. Med. 9 (2003) 685-693
57. Keller P.J., Pampaloni F., and Stelzer E.H.K. Life sciences require the third dimension. Curr. Opin. Cell Biol. 18 (2006) 117-124
58. Khoshyomn S., Lew S., DeMattia J., Singer E.B., and Penar P.L. Brain tumor invasion rate measured in vitro does not correlate with Ki-67 expression. J. Neuro-Oncol. 45 (1999) 111-116
59. Kim J.S., and Lowengrub J.S. Phase field modeling and simulation of three-phase flows. Int. Free Bound. 7 (2005) 435
60. Kim J.S., Kang K., and Lowengrub J.S. Conservative multigrid methods for Cahn-Hilliard fluids. J. Comp. Phys. 193 (2004) 511-543
61. Kim J.S., Kang K., and Lowengrub J.S. Conservative multigrid methods for ternary Cahn-Hilliard systems. Comm. Math. Sci. 12 (2004) 53-77
62. Kopfstein L., and Christofori G. Metastasis: cell-autonomous mechanisms versus contributions by the tumor microenvironment. Cell. Mol. Life Sci. 63 (2006) 449-468
63. Kuiper R.A.J., Schellens J.H.M., Blijham G.H., Beijnen J.H., and Voest E.E. Clinical research on antiangiogenic therapy. Pharmacol. Res. 37 (1998) 1-16
64. Kumar M., Krishnan G., Arumainanthan U., and Singh K. Endoscopic excision of a nasal glioma. Internet J. Otorhinolaryngol. 2 1 (2003)
65. Kunkel P., Ulbricht U., Bohlen P., Brockmann M.A., Fillbrandt R., Stavrou D., Westphal M., and Lamszus K. Inhibition of glioma angiogenesis and growth in vivo by systemic treatment with a monoclonal antibody against vascular endothelial growth factor receptor-2. Cancer Res. 61 (2001) 6624-6628
66. Lah T.T., Alonso M.B.D., and Van Noorden C.J.F. Antiprotease therapy in cancer: hot or not?. Exp. Op. Biol. Ther. 6 (2006) 257-279
67. Lamszus K., Kunkel P., and Westphal M. Invasion as limitation to anti-angiogenic glioma therapy. Acta Neurochir., Suppl. 88 (2003) 169-177
68. Lee H., Lowengrub J.S., and Goodman J. Modeling pinchoff and reconnection in a Hele-Shaw cell. I. The models and their calibration. Phys. Fluids 14 (2002) 492-513
69. Leo P.H., Lowengrub J.S., and Jou H.-J. A diffuse interface model for elastically stressed solids. Acta Metall. 46 (1998) 2113-2130
70. Less J.R., Skalak T.C., Sevick E.M., and Jain R.K. Microvascular architecture in a mammary carcinoma: branching patterns and vessel dimensions. Cancer Res. 51 (1991) 265-273
71. Li C.H., Shan S., Huang Q., Braun R.D., Lanzen J., Hu K., Lin P., and Dewhirst M.W. Initial stages of tumor cell-induced angiogenesis: evaluation via skin window chambers in rodent models. J. Natl. Cancer Inst. 92 (2000) 143-147
72. Li X., Cristini V., Nie Q., and Lowengrub J. Nonlinear three-dimensional simulation of solid tumor growth. Discrete Contin. Dyn. Syst., Ser. B. 7 (2007) 581-604
73. Lockett J., Yin S.P., Li X.H., Meng Y.H., and Sheng S.J. Tumor suppressive maspin and epithelial homeostasis. J. Cell Chem. 97 (2006) 651-660
74. Lowengrub J.S., and Truskinovsky L. Quasi-incompressible Cahn-Hilliard fluids and topological transitions. Proc. R. Soc. Lond., A 454 (1998) 2617-2654
75. Macklin P., and Lowengrub J.S. Evolving interfaces via gradients of geometry-dependent interior Poisson problems: application to tumor growth. J. Comp. Phys. 203 (2005) 191-220
76. Macklin P., and Lowengrub J.S. Nonlinear simulation of the effect of microenvironment on tumor growth. J. Theor. Biol. 245 (2007) 677-704
77. McDougall S.R., Anderson A.R.A., and Chaplain M.A.J. Mathematical modeling of dynamic adaptive tumour-induced angiogenesis: clinical applications and therapeutic targeting strategies. J. Theor. Biol. 241 (2006) 564-589
78. McLean G.W., Carragher N.O., Avizienyte E., Evans J., Brunton V.G., and Frame M.C. The role of focal-adhesion kinase in cancer. A new therapeutic opportunity. Nat. Rev., Cancer 5 (2005) 505-515
79. Naganuma H., Kimurat R., Sasaki A., Fukamachi A., Nukui H., and Tasaka K. Complete remission of recurrent glioblastoma multiforme following local infusions of lymphokine activated killer cells. Acta Neurochir. 99 (1989) 157-160
80. O'Connor J.P.B., Jackson A., Parker G.J.M., and Jayson G.C. DCE-MRI biomarkers in the clinical evaluation of antiangiogenic and vascular disrupting agents. Br. J. Cancer 96 (2007) 189-195
81. Ommaya A.K. Mechanical properties of tissues of the nervous system. J. Biomech. 1 (1968) 127-138
82. Padera T.P., Stoll B.R., Tooredman J.B., Capen D., di Tomaso E., and Jain R. Cancer cells compress intratumour vessels. Nature 427 (2004) 695
83. Page D.L., Anderson T.J., and Sakamoto G. Diagnostic Histopathology of the Breast Churchill (1987), Livingstone, New York 219-222
84. Patan S., Munn L.L., Tanda S., Roberge S., Jain R.K., and Jones R.C. Vascular morphogenesis and remodeling in a model of tissue repair: blood vessel formation and growth in the ovarian pedicle after ovariectomy. Circ. Res. 89 (2001) 723-731
85. Patan S., Tanda S., Roberge S., Jones R.C., Jain R.K., and Munn L.L. Vascular morphogenesis and remodeling in a human tumor xenograft: blood vessel formation and growth after ovariectomy and tumor implantation. Circ. Res. 89 (2001) 732-739
86. Pennacchietti S., Michieli P., Galluzzo M., Mazzone M., Giordano S., and Comoglio P.M. Hypoxia promotes invasive growth by transcriptional activation of the met protooncogene. Cancer Cell 3 (2003) 347-361
87. Plank M.J., and Sleeman B.D. A reinforced random walk model of tumour angiogenesis and anti-angiogenic strategies. Math. Med. (2003) 20135-20181
88. Plank M.J., and Sleeman B.D. Lattice and non-lattice models of tumour angiogenesis. Bull. Math. Biol. 66 (2004) 1785-1819
89. Preusser M., Heinzl H., Gelpi E., Schonegger K., Haberler C., Birner P., Marosi C., Hegi M., Gorlia T., and Hainfellner J.A. Histopathologic assessment of hot-spot microvessel density and vascular patterns in glioblastoma: poor observer agreement limits clinical utility as prognostic factors: a translational research project of the European Organization for Research and Treatment of Cancer Brain Tumor Group. Cancer 107 (2006) 162-170
90. Ridley A.J., Schwartz M.A., Burridge K., Firtel R.A., Ginsberg M.H., Borisy G., Parsons J.T., and Horwitz A.R. Cell migration: integrating signals from front to back. Science 302 (2003) 1704-1709
91. Rofstad E., and Halsor E. Hypoxia-associated spontaneous pulmonary metastasis in human melanoma xenografts: involvement of microvascular hot spots induced in hypoxic foci by interleukin 8. Br. J. Cancer 86 (2002) 301-308
92. Rubenstein J.L., Kim J., Ozawa T., Zhang M., Westphal M., Deen D.F., and Shuman M.A. Anti-VEGF antibody treatment of glioblastoma prolongs survival but results in increased vascular cooption. Neoplasia 2 (2000) 306-314
93. Sahai E. Mechanisms of cancer cell invasion. Curr. Opin. Genet. Dev. 15 (2005) 87-96
94. Sanga S., Sinek J.P., Frieboes H.B., Ferrari M., Fruehauf J.P., and Cristini V. Mathematical modeling of cancer progression and response to chemotherapy. Expert Rev. Anticancer Ther. 6 (2006) 1361-1376
95. Seftor E.A., Meltzer P.S., Kirschmann D.A., Pe'er J., Maniotis A.J., Trent J.M., Folberg R., and Hendrix M.J. Molecular determinants of human uveal melanoma invasion and metastasis. Clin. Exp. Metastasis 19 (2002) 233-246
96. Shweiki D., Itin A., Soffer D., and Keshet E. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 359 (1999) 843-845
97. Sierra A. Metastases and their microenvironments: linking pathogenesis and therapy. Drug Resist. Updat. 8 (2005) 247-257
98. Sinek J., Frieboes H.B., Zheng X., and Cristini V. Two-dimensional chemotherapy simulations demonstrate fundamental transport and tumor response limitations involving nanoparticles. Biomed. Microdev. 6 4 (2004) 297-309
99. Skinner S.A. Microvascular architecture of experimental colon tumors in the rat. Cancer Res. 50 (1990) 2411-2417
100. Steeg P.S. Angiogenesis inhibitors: motivators of metastasis?. Nat. Med. 9 (2003) 822-823
101. Sun S., Wheeler M.F., Obeyesekere M., and Patrick Jr. C. Multiscale angiogenesis modeling using mixed finite element methods. Multiscale Model. Simul. 4 (2005) 1137-1167
102. Takano S., Yoshii Y., Kondo S., Suzuki H., Maruno T., Shirai S., and Nose T. Concentration of vascular endothelial growth factor in the serum and tumor tissue of brain tumor patients. Cancer Res. 56 (1996) 2185-2190
103. Toker A., and Yoeli-Lerner M. Akt signaling and cancer: surviving but not moving on. Cancer Res. 66 (2006) 3963-3966
104. Tysnes B.B., and Mahesparan R. Biological mechanisms of glioma invasion and potential therapeutic targets. J. Neurooncol. 53 (2001) 129-147
105. Vajkoczy P., Farhadi M., Gaumann A., Heidenreich R., Erber R., Wunder A., Tonn J.C., Menger M.D., and Breier G. Microtumor growth initiates angiogenic sprouting with simultaneous expression of VEGF, VEGF receptor-2, and angiopoietin-2. J. Clin. Invest. 109 (2002) 777-785
106. van Kempen L.C.L.T., Ruiter D.J., van Muijen G.N.P., and Coussens L.M. The tumor microenvironment: a critical determinant of neoplastic evolution. Eur. J. Cell Biol. 82 (2003) 539-548
107. Wise S.M., Lowengrub J.S., Kim J.S., and Johnson W.C. Efficient phase-field simulation of quantum dot formation in a strained heteroepitaxial film. Superlattices Microstruct. 36 (2004) 293-304
108. Wolf K., and Friedl P. Molecular mechanisms of cancer cell invasion and plasticity. Br. J. Dermatol. 154 (2006) 11-15
109. Wurzel M., Schaller C., Simon M., and Deutsch A. Cancer cell invasion of brain tissue: guided by a prepattern?. J. Theor. Med. 6 (2005) 21-31
110. Yamaguchi H., Wyckoff J., and Condeelis J. Cell migration in tumors. Curr. Opin. Cell Biol. 17 (2005) 559-564
111. Yin S.P., Lockett J., Meng Y.H., Biliran H., Blouse G.E., Li X.H., Reddy N., Zhao Z.M., Lin X.L., Anagli J., Cher M.L., and Sheng S.J. Maspin retards cell detachment via a novel interaction with the urokinase-type plasminogen activator/urokinase-type plasminogen activator receptor system. Cancer Res. 66 (2006) 4173-4181
112. Zagzag, D., Amirnovin, R.,Greco, M.A., Yee, H., Holash, J., Wiegand, S.J., Zabski, S., Yancopoulos, G.D., Grumet, M., 2000. Vascular apoptosis and involution in gliomas precede neovascularization: a novel concept for glioma growth and angiogenesis.
113. Zheng X., Wise S., and Cristini V. Nonlinear simulation of tumor necrosis, neo-vascularization and tissue invasion via an adaptive finite-element/level-set method. Bull. Math. Biol. 67 (2005) 211-259